NOVADOZ PHARMACEUTICALS LLC

FDA Regulatory Profile

NOVADOZ PHARMACEUTICALS LLC appears in FDA public data with 1 recall, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0300-2026, Class III) was initiated on December 15, 2025.

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
0
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-0300-2026Class IIIGlycopyrrolate Oral Solution, 1 mg/5 mL, 16 oz. (473 mL), Rx only, Manufactured by: MSN PharmaceuticDecember 15, 2025